In phase I, the correlation between hMAM, Myc, and ErbB2 mRNA expression and tumor stage was significant (P < 0.001), but no correlation was found between MUC, ER, CEA, Ki-67, CK19, and HER2 and tumor stage. Here, ERBB2 is linked to neoplasm.